• Source: VK2735

VK2735 is a dual agonist of the GLP-1 receptor and GIP receptor, with a similar mechanism of action as tirzepatide, which acts on the same receptors. It is injectable and is being developed by Viking Therapeutics.




References

Kata Kunci Pencarian:

• VK2735
• Glucagon-like peptide-1 receptor